Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports
![dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b "dpp-4_inhibitors [TUSOM | Pharmwiki]")
dpp-4_inhibitors [TUSOM | Pharmwiki]
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2 - ScienceDirect
Alternative zu Insulin: Warum es in späten Typ-2-Diabetes-Stadien oft keine gibt
The regulatory role of DPP4 in atherosclerotic disease | Cardiovascular Diabetology | Full Text
Glucagon.com
Effect of dual inhibition of DPP4 and SGLT2 on tacrolimus‐induced diabetes mellitus and nephrotoxicity in a rat model - Ko - 2022 - American Journal of Transplantation - Wiley Online Library
DPP-4 Inhibitors
DPP4 in Cardiometabolic Disease | Circulation Research
PDB-101: Global Health: Diabetes Mellitus: Drugs: DPP4 inhibitor: DPP4
Cells | Free Full-Text | Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review
DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy - ScienceDirect
Ausgabe 1/2017: Update Diabetes mellitus
Frontiers | DPP4 in Diabetes
DPP-4-Inhibitoren in der Therapie des Diabetes mellitus Typ 2 - YouTube
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition - ScienceDirect
Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials | The BMJ
Dipeptidyl peptidase-4 inhibitor - Wikipedia
Discovery of Actions, so far Unknown, of DPP-4 Inhibitors, a Drug for Diabetes | Kanazawa University
KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes - ScienceDirect
Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway | Cell Death Discovery
COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? - Bassendine - 2020 - Journal of Diabetes - Wiley Online Library
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications | Diabetology & Metabolic Syndrome | Full Text
